Evidence map›Paper›PMID 34035091›Full record

ArticleBMJ open2021

Comparison of short-term outcomes and quality of life in totally laparoscopic distal gastrectomy and totally robotic distal gastrectomy for clinical stage I-III gastric cancer: study protocol for a multi-institutional randomised clinical trial.

Hao Cui, Bo Cao, Guoxiao Liu, Hongqing Xi, Zhida Chen, Wenquan Liang, Kecheng Zhang, Jianxin Cui, Tianyu Xie, Huan Deng and 3 more

Open access · goldAbstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 8 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Hao CuiDepartment of General Surgery & Institute of General Surgery, Chinese PLA General Hospital, Beijing, China.ORCID 0000-0003-1185-5322
Bo CaoDepartment of General Surgery & Institute of General Surgery, Chinese PLA General Hospital, Beijing, China.ORCID 0000-0003-4623-7348
Guoxiao LiuDepartment of General Surgery & Institute of General Surgery, Chinese PLA General Hospital, Beijing, China.
Hongqing XiDepartment of General Surgery & Institute of General Surgery, Chinese PLA General Hospital, Beijing, China.
Zhida ChenDepartment of General Surgery & Institute of General Surgery, Chinese PLA General Hospital, Beijing, China.
Wenquan LiangDepartment of General Surgery & Institute of General Surgery, Chinese PLA General Hospital, Beijing, China.
Kecheng ZhangDepartment of General Surgery & Institute of General Surgery, Chinese PLA General Hospital, Beijing, China.
Jianxin CuiDepartment of General Surgery & Institute of General Surgery, Chinese PLA General Hospital, Beijing, China.
Tianyu XieDepartment of General Surgery & Institute of General Surgery, Chinese PLA General Hospital, Beijing, China.
Huan DengDepartment of General Surgery & Institute of General Surgery, Chinese PLA General Hospital, Beijing, China.
Yun TangDepartment of General Surgery & Institute of General Surgery, Chinese PLA General Hospital, Beijing, China.
Lin ChenDepartment of General Surgery & Institute of General Surgery, Chinese PLA General Hospital, Beijing, China.
Bo WeiDepartment of General Surgery & Institute of General Surgery, Chinese PLA General Hospital, Beijing, China weibo@vip.163.com.
Chinese PLA General Hospital · CNNankai University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionLaparoscopic distal gastrectomy (LDG) is regarded as a standard treatment for patients with clinical stage I-III gastric cancer. With the popularisation of the METHODS AND ANALYSIS: This study is a prospective, multi-institutional, open-label randomised clinical trial that will recruit 722 patients with a 1:1 ratio (361 patients in the TLDG group and 361 patients in the TRDG group) from eight large-scale gastrointestinal medical centres in China. The primary endpoint is 30-day postoperative morbidity. The secondary endpoints include QOL, 30-day severe postoperative morbidity and mortality, anastomotic-related complication rate, conversion to open surgery rate, intraoperative and postoperative indicators, operative and total costs during hospitalisation, 1-year overall survival and disease-free survival. QOL is determined by the The European Organization for Reasearch and Treatment of Cancer Quality of Life Questionnare-Core 30 and Stomach22 (EORTC QLQ-C30 and STO22) questionnaires which are completed before surgery and 1, 3, 6 months, and 1 year after surgery. χ ETHICS AND DISSEMINATION: This trial was approved by the Ethics Committee of the Chinese PLA General Hospital. The trial's results will be disseminated via peer-reviewed scientific journals and conference presentations. TRIAL REGISTRATION NUMBER: ChiCTR2000032670.

Indexed as

LaparoscopyRobotic Surgical ProceduresStomach NeoplasmsChinaGastrectomyHumansProspective StudiesQuality of LifeRandomized Controlled Trials as TopicTreatment Outcomeadult surgerygastrointestinal tumours

Identifiers

PMID34035091
PMCPMC8154927
OpenAlexW3165426395

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.